aid: calixa-therapeutics
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/calixa-therapeutics.png
name: Calixa Therapeutics
description: 'Calixa Therapeutics was a privately held, San Diego-based biopharmaceutical
  company focused on developing antibiotics to treat serious infections caused by
  multi-drug-resistant Gram-negative bacterial pathogens. Its lead compound, CXA-201
  (later ceftolozane/tazobactam), was an intravenous therapy for serious hospital-acquired
  Gram-negative infections. Calixa was acquired by Cubist Pharmaceuticals in December
  2009 for approximately $92.5 million (plus up to $310 million in milestone payments)
  and no longer operates as an independent company. It has no public developer or API
  surface. This profile exists in the API Evangelist network as a portfolio-lead stub
  associated with canaan-partners; there are no API artifacts to enrich because it
  is a defunct pharmaceutical company, not an API provider.'
url: https://raw.githubusercontent.com/api-evangelist/calixa-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- canaan-partners
x-tier: stub
x-tier-reason: portfolio-lead
x-status: acquired
x-status-note: Acquired by Cubist Pharmaceuticals in December 2009; not an independent
  operating company and has no public API surface.
x-acquired-by: cubist-pharmaceuticals
x-acquired-date: '2009-12-16'
x-industry: pharmaceuticals
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-18'
tags:
- Company
- Pharmaceuticals
- Biotechnology
- Antibiotics
- Anti-Infectives
- Drug Development
- Life Sciences
- Healthcare
- Acquired
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence